Conférences - Législation en médecine et pharmacologie

Sélecionner un pays:
Allemagne (6) - Belgique (2) - Inde (3) - Royaume-Uni (3) - Suisse (1) - États-Unis (22)

TOUS LES PAYS

1
Workshop — 2 Day Workshop: Preparing For The New EU Medical Device Regulations (MDR)
21 fév 2018 - 22 fév 2018 • Hollywood, États-Unis
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.in
Identifiant de l'évènement:
974119
2
Workshop — 2 Days Workshop: Preparing For The New EU Medical Device Regulations (MDR)
21 fév 2018 - 22 fév 2018 • Burlingame, CA, États-Unis
Résumé:
The new Medical Device Regulations (MDR) were published in the Official Journal of the European Union on May 5, 2017. From that date, manufacturers, suppliers, Notified Bodies, and national competent authorities have a transition period of three years to comply with the new set of rules. Given the large scale of changes, there is great pressure on all actors to analyze the MDR, conduct impact assessments, and implement compliant processes. After May 2020, non-compliance threatens CE-mark certification, access to the European market, or, in the case of Notified Bodies, re-designation.
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1006797
3
Training — Information Governance in Health and Social Care: Ensuring Compliance with GDPR
23 fév 2018 • Londres, Royaume-Uni
Résumé:
With an opening address from Dawn Monaghan Chair Health and Social Care Working Group on GDPR & Head of Data Sharing and Privacy NHS England, this National Conference focuses on Information Governance in Health and Social Care, ensuring demonstrable compliance with the General Data Protection Regulation (GDPR) which comes into force in May 2018. Through national updates, expert led extended interactive sessions and practical case studies the conference will support you to ensure compliance in your service. Follow this conference on Twitter #GDPRNHS A 20% discount is available by quoting ref: hcuk20c-s when booking.
Contact:
8 Wilson Drive, Ottershaw, Surrey KT16 0NT;     Tél.: 0044/1932 429933;     Email.: kerry@hc-uk.org.uk
Sujets:
Social Care, Data Sharing, Data Protection, Information Sharing
Identifiant de l'évènement:
979494
4
NDAs and INDs for Orally-Administered Drug Products
28 fév 2018 • Fremont, États-Unis
Contact:
Event Manager;     Tél.: [18004479407];     Email.: support@compliance4All.com
Sujets:
medical trainings, Compliance trainings, healthcare trainings, Online trainings
Identifiant de l'évènement:
979055
5
How Ensuring Data Integrity in Method Validations
28 fév 2018 • Fremont, États-Unis
Résumé:
This section plays a major role in both purchasing and in production. It is a major contributor to determine whether your supplier and manufacturing process are working effectively.
Contact:
Event Manager;     Tél.: [18004479407];     Email.: support@compliance4All.com
Sujets:
medical trainings, Compliance trainings, healthcare trainings, Online trainings
Identifiant de l'évènement:
979010
6
A Legal Compliance Program When Billing Durable Medical Equipment
01 mar 2018 • Aurora, États-Unis
Résumé:
Learn that treating your Medicare patients with Durable Medical Equipment can be great for patient clinical outcomes, a great revenue stream and can be legally compliant. It will also lower healthcare costs. However one must know how to get the proper licensure and know the Federal & State Guidelines.
Contact:
Training Doyens;     Tél.: [7209961616];     Email.: support@trainingdoyens.com
Sujets:
medical device training programs, medical equipment repair course, medical equipment repair training, medical equipment training
Identifiant de l'évènement:
1015178
7
CfPIE - The Center for Professional Innovation & Education — Product Quality Reviews
01 mar 2018 - 03 mar 2018 • Los Angeles, CA, États-Unis
Résumé:
The purpose of the course is to educate the participant in the regulatory requirements for the Annual Product Review while demonstrating the power of the Periodic or Annual Product Review as a Quality Assurance and Quality Improvement tool. We will discuss how the Product Review supports the US, EU and Canadian GMPS while applying the ICH Q10, Pharmaceutical Quality System elements of Process Performance and Product Quality Monitoring, CAPA, Change Management and Management Review, as well as the enablers of Information Management and Risk Management. Discussion will also include the impact of the FDA 2011 Process Validation guidance and the potential impact of the proposed FDA requirement for Quality Metrics on the Product Review.
Contact:
Registration Department;     Tél.: [1-610-648-7550];     Email.: info@cfpie.com
Sujets:
The regulatory requirements for the Annual Product Review The Annual Product Review as it relates to other required and expected reports The Annual Product Review as part of a contemporary Quality System What should be included in the Product Review The Product Review as a source of recommendations for process improvement Management involvement and responsibility The Product Review in support of stage 3 of process validation, continued process verification The Product Review process as a user of, and contributor to, the corporate knowledge The application of quality metrics to the Product Review process
Identifiant de l'évènement:
1006800
8
Training — Clinical Audit Summit 2018: Clinical Audit for Improvement
05 mar 2018 • Londres, Royaume-Uni
Résumé:
Chaired by Carl Walker Chair National Quality Improvement & Clinical Audit Network (NQICAN) this one day conference will bring together an exceptional gathering of leading practitioners, clinicians, and policy makers to set out the major developments, promote innovative areas of clinical audit, and debate the key challenges affecting you and your clinical audit practice. A series of national updates, best practice case studies, extended sessions and poster presentation will provide you with a practical guide to clinical audit for improvement with a particular focus on developing effective local clinical audit leading to audit recommendations that change practice and improve patient care. Hot topic focus issues this year will be on Clinical Audit Leadership, Mortality Audit and GDPR. Follow this conference on Twitter #ClinicalAudit2018 A 20% discount is available by quoting ref: hcuk20c-s when booking.
Contact:
8 Wilson Drive, Ottershaw, Surrey KT16 0NT;     Tél.: 0044/1932 429933;     Email.: kerry@hc-uk.org.uk
Sujets:
Clinical Audit, Policy and Practice
Identifiant de l'évènement:
1003406
9
Course - The Center for Professional Innovation & Education — Aseptic Processing in the Manufacture of Biotech and Pharmaceutical Products
05 mar 2018 - 06 mar 2018 • Boston, MA, États-Unis
Résumé:
Whether for biopharmaceutical or pharmaceutical applications, this course presents the technical basics that govern aseptic processing and provides practical advice for attendees to troubleshoot and manage their aseptic operations. Attendees from the sterile medical device industry have also benefited from this training.
Contact:
Olivia Carlin;     Tél.: [1-610-648-7550];     Email.: info@cfpie.com
Sujets:
Risk Management, Containers, Package Integrity, Depyrogenation, Lyophilization, Media Fills
Identifiant de l'évènement:
1013523
10
Workshop — 2018 : 2 Days Conference on UnAnnounced Audits are You Prepared?
08 mar 2018 - 09 mar 2018 • Ahmedabad, Inde
Résumé:
The Indian Pharma industry has been under scrutiny over the last few years and has facedaudits across the year leading to alarming warning letters being received and facing repetitive audits. This has not only impacted reputation of the companies, but it has become imperative for all pharma companies to bring 24/7 quality culture to become all time audit ready.
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1003048
11
Workshop — 2018 : 2 Days Conference on UnAnnounced Audits are You Prepared?
08 mar 2018 - 09 mar 2018 • Ahmedabad | India, Inde
Résumé:
The Indian Pharma industry has been under scrutiny over the last few years and has facedaudits across the year leading to alarming warning letters being received and facing repetitive audits. This has not only impacted reputation of the companies, but it has become imperative for all pharma companies to bring 24/7 quality culture to become all time audit ready.
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.in
Identifiant de l'évènement:
1006730
12
Workshop — 2 Day Workshop: FDA Inspections: What Regulators Expect and How to Prepare
14 mar 2018 - 15 mar 2018 • San Diego, États-Unis
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.in
Identifiant de l'évènement:
974118
13
Workshop — 2 Day Workshop: FDA Inspections: What Regulators Expect and How to Prepare
14 mar 2018 - 15 mar 2018 • San Diego CA, États-Unis
Résumé:
This is a practical, hands-on course designed to provide pharmaceutical, biopharmaceutical, biologics and medical device professionals with the information and tools they require to prepare for and manage an FDA inspection efficiently, effectively and successfully. Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions.
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1006789
14
Pharma Regulatory 2018
15 mar 2018 • Mumbai, Inde
Résumé:
Virtue Insight brings you it’s first Pharma Regulatory 2018, focusing on the clarification and interpretation to the most critical regulatory guidelines faced by the Indian Pharma companies.This unique event will bring key stakeholders gather with the aim of promoting and undertaking to continue work towards a more efficient pharma regulatory system. In the spirit of constructive cooperation, this event brings together representatives from the industry and regulators as well as healthcare professionals. The summit features government and regulatory authorities and expert insights to help you tackle and overcome these regulatory challenges, and to improve the drug and device approval processes for pharmaceutical, biopharmaceutical and medical device companies.
Contact:
Kavitha;     Tél.: [+91 44 64998743];     Email.: kavitha@virtueinsight.co.in
Identifiant de l'évènement:
981940
15
Workshop — 2 Day Workshop: Human Error: Why Human Error is the biggest downtime problem in the manufacturing sector and how to investigate, control, reduce, and prevent to improve results.
15 mar 2018 - 16 mar 2018 • Hollywood, États-Unis
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.in
Identifiant de l'évènement:
974095
16
Workshop — 2 Day Workshop: Human Error: Why Human Error is the biggest downtime problem in the manufacturing sector and how to investigate, control, reduce, and prevent to improve results.
15 mar 2018 - 16 mar 2018 • New Brunswick, États-Unis
Résumé:
Small mistakes can lead to big disasters—just ask the scientists and engineers who worked on the Mars Climate Orbiter: a $327.6-million USD spacecraft that was destroyed because of a failure to properly convert between units of measurement.Any manufacturer who’s had to shut down an entire production line because someone misread a label or forgot to “carry the one” can sympathize. In fact, according to a new study from Vanson Bourne, manufacturers know the pain of unplanned downtime due to human error better than anyone.
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1006681
17
FDA's Medical Device Software Regulation Strategy
20 mar 2018 - 21 mar 2018 • Zurich, Suisse
Résumé:
The growth of the medical software industry outpaces the design of FDA's regulatory process. In some instances clinicians have weighed the risk of software failure against the benefits of using a device at all. Device software is often used in conjunction with other software-based devices, but their interoperability was never anticipated.Note: Use coupon code and get 20% off on registration and this offer is not valid for with stay registration.
Contact:
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets:
Seminar by Ex-FDA Official, Regulatory profile for software products, FDA mobile apps regulation, medical device software functionality, FDA and NIST software guidance
Identifiant de l'évènement:
969758
18
Workshop — 1 Day workshop GMP’s in practice: quality systems, common sense compliance, and application
22 mar 2018 • Washington D.C, États-Unis
Résumé:
This course covers all GMP 211 sub-parts including Part 11 and electronic batch records. Also, this course covers more than 30 elements of a modern quality system, it’s requirements, expectations, and examples. Each element is explored with applicable regulation from US FDA, Health Canada, European Union WHO and ICH (for multinationals).
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1003025
19
Workshop — 1 Day workshop GMP’s in practice: quality systems, common sense compliance, and application
22 mar 2018 • Washington D.C, États-Unis
Résumé:
Course"GMP’s in practice: quality systems, common sense compliance, and application" has been pre-approved by RAPS as eligible for up to 6 credits towards a participant’s RAC recertification upon full completion This course covers all GMP 211 sub-parts including Part 11 and electronic batch records. Also, this course covers more than 30 elements of a modern quality system, it’s requirements, expectations, and examples. Each element is explored with applicable regulation from US FDA, Health Canada, European Union WHO and ICH (for multinationals).
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1006799
20
The FDA Drug Approval Process
22 mar 2018 - 23 mar 2018 • Londres, Royaume-Uni
Résumé:
This seminar, by a US lawyer with over 40 years of experience dealing with pharmaceutical regulation in the United States and Europe, will provide a general introduction to all aspects of the US drug approval process. It will also cover the organisation and structure of the Food and Drug Administration, recent amendments to the FDA’s procedures designed to expedite the testing and approval of new medicines and other topics of current interest.
Identifiant de l'évènement:
956675
21
2nd Interim Analysis Symposium (EXL)A
26 mar 2018 - 27 mar 2018 • Philadelphia, PA, États-Unis
Résumé:
The 2nd Interim Analysis Symposium will provide drug safety and clinical operations teams with best practices and tried-and-true strategies that will enhance the capacity at which organizations can produce upstanding reports about the results of their ongoing studies and expedite effective products to market.
Identifiant de l'évènement:
957027
22
2nd Product Complaints Forum (EXL)A
26 mar 2018 - 27 mar 2018 • Philadelphia, PA, États-Unis
Résumé:
ExL Events’ 2nd Product Complaints Forum will provide insight into how to improve the management of product complaints and potential recalls. This program will feature case studies, panel sessions, and two tracks designed to deliver information for pharmaceutical, biotechnology, and medical device professionals involved in all stages of handling product complaints and potential recalls.
Identifiant de l'évènement:
957026
23
CfPIE - The Center for Professional Innovation & Education, Inc. — Computer System Validation
12 avr 2018 - 13 avr 2018 • Berlin, Allemagne
Résumé:
This computer system validation course focuses on developing and implementing regulated computer systems with an appropriate level of documented evidence to satisfy FDA expectations. The course targets deliverable document content and how to avoid rework and unnecessary expense through a proactive approach. The core elements of a satisfactory computer validation program will be emphasized.
Contact:
Olivia Carlin;     Tél.: [1-610-648-7550];     Email.: info@cfpie.com
Sujets:
21 CFR part 11, computer validation, GAMP 5, Auditing GXP, Part 810, Part 211, Q7A GMPs, Software Validation
Identifiant de l'évènement:
1009950
Sujets apparentés:
24
CfPIE - The Center for Professional Innovation & Education — Good Manufacturing Practices Training | GMP Course
18 avr 2018 - 20 avr 2018 • Berlin, Allemagne
Résumé:
This Good Manufacturing Practices training covers the foundations of the regulations that control the manufacture and distribution of pharmaceutical, biologic and medical devices sold in the United States. Current Good Manufacturing Practices (cGMPs) are defined for all Food and Drug Administration (FDA) Regulated products in Title 21 CFR 210/211. Application of the regulations will be discussed and examples provided throughout the GMP course. Attendees will gain an understanding of how knowledge of the regulations facilitates efficient and cost effective production and problem resolution.
Contact:
Olivia Carlin;     Tél.: [1-610-648-7550];     Email.: info@cfpie.com
Sujets:
GMP, Change Control, Master Plan, Laboratory Controls
Identifiant de l'évènement:
1009993
Sujets apparentés:
25
Workshop — 2 Day Workshop Product Registration and Navigating the Approval Process with Regulatory Authorities in Asia Pacific, Europe, Middle East and The Americas
25 avr 2018 • Boston, États-Unis
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.in
Identifiant de l'évènement:
974127
26
Workshop — 2 Day Workshop Product Registration and Navigating the Approval Process with Regulatory Authorities in Asia Pacific, Europe, Middle East and The Americas
25 avr 2018 - 26 avr 2018 • Boston,MA, États-Unis
Résumé:
Description

One of the first steps towards selling a Class II medical device or IVD in the United States is to file a Premarket Notification with the FDA, also known as an FDA 510(k) submission. Technically, the FDA does not "approve" medical devices or IVDs for sale under the 510(k) process; the agency gives "clearance" for them to be sold in the U.S. We use the term "FDA approval" for simplicity. Premarket approval (PMA) is the FDA process of scientific and regulatory review to evaluate the safety and effectiveness of Class III medical devices.

Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1003056
27
Workshop — Current issues in assuring data integrity in life sciences : 2 Days Seminar
25 avr 2018 - 26 avr 2018 • San Diego CA, États-Unis
Résumé:
Data Integrity is a major concern of regulatory agencies worldwide as evidenced by the increasing number of Warning Letters issued in that area. Some managements have proceeded to implement data integrity programs on the lines of those implemented in “big data”. This has resulted in the escalation of costs and it is disproportionate to the benefits gained. Some even wonder why they continue to receive Warning Letters in spite of spending the dollars to implement programs such as Data Governance etc. etc.
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1006682
28
Workshop — 2 Day Workshop Product Registration and Navigating the Approval Process with Regulatory Authorities in Asia Pacific, Europe, Middle East and The Americas
25 avr 2018 - 26 avr 2018 • Boston,MA, États-Unis
Résumé:
One of the first steps towards selling a Class II medical device or IVD in the United States is to file a Premarket Notification with the FDA, also known as an FDA 510(k) submission. Technically, the FDA does not "approve" medical devices or IVDs for sale under the 510(k) process; the agency gives "clearance" for them to be sold in the U.S. We use the term "FDA approval" for simplicity. Premarket approval (PMA) is the FDA process of scientific and regulatory review to evaluate the safety and effectiveness of Class III medical devices.
Contact:
Conference Manager;     Tél.: [347 282-5400];     Email.: support@worldcomplianceseminars.com
Identifiant de l'évènement:
1006768
29
CfPIE - The Center for Professional Innovation & Education — CMC Regulatory Compliance for Biopharmaceuticals & Biosimilars
23 mai 2018 - 25 mai 2018 • Berlin, Allemagne
Résumé:
This course will help the attendee to develop a CMC regulatory compliance strategy for biopharmaceuticals, biosimilars and other biologics, addressing the five core elements that comprise an effective strategy: (1) embracing the full spectrum of CMC activities, (2) addressing unique requirements for specific biologic manufacturing processes, (3) addressing unique requirements for specific biologic products, (4) aligning with the strategic ICH Q8/Q9/Q10 guidances, and (5) applying a clinical phase-appropriate approach. The critical importance of communicating CMC regulatory compliance strategy with the regulatory authorities at CMC-focused meetings will be stressed. In addition, this course will also help the attendee to better understand the CMC regulatory compliance requirements for Quality by Design applications and for biosimilars.
Contact:
Olivia Carlin;     Tél.: [1-610-648-7550];     Email.: info@cfpie.com
Sujets:
compliance, biologics, FDA, EMA, regulatory review pathways, IND, NDA, BLA, MAA
Identifiant de l'évènement:
1009985
Sujets apparentés:
30
CfPIE - The Center for Professional Innovation & Education — Preparing the CMC Section for MAAs, IMPDs
30 mai 2018 - 31 mai 2018 • Berlin, Allemagne
Résumé:
This course includes an overview of the relevant guidelines and the organization of the CTD, detailed information and discussions related to each element required in the drug substance and drug product sections of MAAs. The course will emphasize the requirements related to drug substance starting materials, drug substance and drug product specifications, impurities, stability, manufacturing and pharmaceutical development. It will also discuss the use of Drug Master Files (DMF), Certificates of Suitability (CEPs) and preparation of the CTD Quality Overall Summary (Module 2).
Contact:
Olivia Carlin;     Tél.: [1-610-648-7550];     Email.: info@cfpie.com
Sujets:
MAA, CTD, drug substance, purity, stability, DMF, Certificates of Suitability, CEP, CMC, chemistry manufacturing and controls
Identifiant de l'évènement:
1010034
Sujets apparentés:
31
4th Annual ComplianceOnline Medical Device Summit 2018
07 jui 2018 - 08 jui 2018 • San Francisco, États-Unis
Résumé:
Plan for successfully executing regulatory inspections by providing industry best practices. Panel discussions led by the former FDA office bearers and industry experts will provide a set of comprehensive strategies on how to prepare for and manage an FDA inspection, including how to follow-up and closing out 483s or Warning Letters. Attending this summit will enable you to improve and better prepare for your next inspections.
Contact:
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Identifiant de l'évènement:
954430
32
Gordon Research Seminar — Drug Safety
09 jui 2018 - 10 jui 2018 • Stonehill College, Easton, MA, États-Unis
Sujets:
Drug Safety in the Modern Development Landscape: Innovations from Industry, Academia, and Government
Identifiant de l'évènement:
960055
33
Gordon Research Conference — Drug Safety
10 jui 2018 - 15 jui 2018 • Stonehill College, Easton, MA, États-Unis
Sujets:
Contemporary Advances and Challenges in Drug Safety Assessment
Identifiant de l'évènement:
960001
34
Course — European Regulatory Procedures - EMA & National Requirements
13 sep 2018 - 14 sep 2018 • Berlin, Allemagne
Résumé:
This course will give participants the necessary overview of the application procedures and regulatory filing pathways used within Europe to grant marketing authorisations for medicinal products, and of the agencies and institutions that control the regulatory process. Special focus will be given to the European Medicines Agency (EMA) and the Centralised Procedure (CP), with the role of the national health authorities and other EU bodies in the Mutual Recognition Procedure (MRP) and Decentralised Procedure (DCP) explained also. Factors affecting the choice of procedure will be discussed, as well as best practice in the management of the procedures. A workshop session will engage participants in a case study evaluating the options for submission of a marketing authorization application.
Contact:
Olivia Carlin;     Tél.: [+1-610-648-7550];     Email.: info@cfpie.com
Sujets:
European Regulatory Procedures, Regulation, EMA, Centralised Procedure, European Medicines Agency, Filing Strategy, Labeling
Identifiant de l'évènement:
1012395
Sujets apparentés:
35
The Pharma Licensing Negotiation Course
27 sep 2018 - 28 sep 2018 • Bruxelles, Belgique
Résumé:
Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.
Contact:
Annelies Swaan;     Tél.: [+32 2 709 01 42];     Email.: annelies.swaan@celforpharma.com
Identifiant de l'évènement:
1009922
36
Course — Filing Variations in the European Union
07 nov 2018 - 08 nov 2018 • Berlin, Allemagne
Résumé:
The course is designed to provide individuals with an in-depth awareness of the rules and procedures for filing variations and extensions. Understanding and applying the rules will ensure that you can file the variations successfully and avoid rejections.
Contact:
Olivia Carlin;     Tél.: [+1-610-648-7550];     Email.: info@cfpie.com
Sujets:
filing, extensions, Marketing Authorizations, filing variations, CMD, Submission, Timeline
Identifiant de l'évènement:
1012484
37
The Pharmaceutical Out-licensing Course
27 nov 2018 - 28 nov 2018 • Bruxelles, Belgique
Résumé:
Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.
Contact:
Annelies Swaan;     Tél.: [+32 2 709 01 42];     Email.: annelies.swaan@celforpharma.com
Identifiant de l'évènement:
1009954


Conference-Service.com met la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

AIP Conference Proceedings
AIP Conference Proceedings

Dernière mise jour: 12 Février 2018